Opiant Pharmaceuticals, Inc.

NORTHERN TRUST CORP

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

Shares

38,679

Value ($000)

784

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	784	0.0%	38,679	12/31/2022
2022 Q3	11/14/2022	418	0.0%	38,924	9/30/2022
2022 Q2	8/12/2022	449	0.0%	37,426	6/30/2022
2022 Q1	5/13/2022	794	0.0%	37,078	3/31/2022
2021 Q4	2/8/2022	1,273	0.0%	37,850	12/31/2021
2021 Q3	11/15/2021	976	0.0%	37,898	9/30/2021
2021 Q2	8/13/2021	507	0.0%	37,958	6/30/2021
2021 Q1	5/12/2021	343	0.0%	32,290	3/31/2021
2020 Q4	2/11/2021	415	0.0%	51,634	12/31/2020
2020 Q3	11/16/2020	447	0.0%	59,731	9/30/2020
2020 Q2	8/14/2020	519	0.0%	57,383	6/30/2020
2020 Q1	5/14/2020	451	0.0%	47,080	3/31/2020
2019 Q4	2/14/2020	671	0.0%	46,605	12/31/2019